Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03485547
Brief Title: Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

First Submitted : March 27, 2018
First Submitted that Met QC Criteria : March 30, 2018
First Posted : April 2, 2018

Last Update Submitted that Met QC Criteria : October 12, 2018
Last Update Posted : October 15, 2018